A Seamless, Phase 1b/2 Multiple Ascending Dose/Proof of Concept Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

Purpose of Study:

The XTMAB16 Study is an early phase clinical research study that is testing an investigational medication for adults diagnosed with pulmonary sarcoidosis.

Study Dates:
July 15, 2023 - April 30, 2026

Type of Study:
Pre-Market

Study Design:
Controlled Design

Study Location:
NC

Lead Institution:
East Carolina University

Sponsors:

Xentria, Inc.

Contact:

Noopur Singh
773-372-3674
[email protected]

ClinicalTrails.gov Identifier:
NCT05890729

Register for Trial
Asthma Basics Workshop - National
, | Apr 17, 2024
Asthma Basics Workshop - National
, | May 07, 2024